Literature DB >> 22740582

Targeted maximum likelihood estimation for dynamic treatment regimes in sequentially randomized controlled trials.

Paul H Chaffee1, Mark J van der Laan.   

Abstract

Sequential Randomized Controlled Trials (SRCTs) are rapidly becoming essential tools in the search for optimized treatment regimes in ongoing treatment settings. Analyzing data for multiple time-point treatments with a view toward optimal treatment regimes is of interest in many types of afflictions: HIV infection, Attention Deficit Hyperactivity Disorder in children, leukemia, prostate cancer, renal failure, and many others. Methods for analyzing data from SRCTs exist but they are either inefficient or suffer from the drawbacks of estimating equation methodology. We describe an estimation procedure, targeted maximum likelihood estimation (TMLE), which has been fully developed and implemented in point treatment settings, including time to event outcomes, binary outcomes and continuous outcomes. Here we develop and implement TMLE in the SRCT setting. As in the former settings, the TMLE procedure is targeted toward a pre-specified parameter of the distribution of the observed data, and thereby achieves important bias reduction in estimation of that parameter. As with the so-called Augmented Inverse Probability of Censoring Weight (A-IPCW) estimator, TMLE is double-robust and locally efficient. We report simulation results corresponding to two data-generating distributions from a longitudinal data structure.

Entities:  

Mesh:

Year:  2012        PMID: 22740582      PMCID: PMC6084784          DOI: 10.1515/1557-4679.1406

Source DB:  PubMed          Journal:  Int J Biostat        ISSN: 1557-4679            Impact factor:   0.968


  17 in total

1.  Estimation of survival distributions of treatment policies in two-stage randomization designs in clinical trials.

Authors:  Jared K Lunceford; Marie Davidian; Anastasios A Tsiatis
Journal:  Biometrics       Date:  2002-03       Impact factor: 2.571

2.  Optimal estimator for the survival distribution and related quantities for treatment policies in two-stage randomization designs in clinical trials.

Authors:  Abdus S Wahed; Anastasios A Tsiatis
Journal:  Biometrics       Date:  2004-03       Impact factor: 2.571

3.  Collaborative targeted maximum likelihood for time to event data.

Authors:  Ori M Stitelman; Mark J van der Laan
Journal:  Int J Biostat       Date:  2010       Impact factor: 0.968

4.  Dynamic regime marginal structural mean models for estimation of optimal dynamic treatment regimes, Part II: proofs of results.

Authors:  Liliana Orellana; Andrea Rotnitzky; James M Robins
Journal:  Int J Biostat       Date:  2010-03-03       Impact factor: 0.968

5.  Weighted Kaplan-Meier estimators for two-stage treatment regimes.

Authors:  Sachiko Miyahara; Abdus S Wahed
Journal:  Stat Med       Date:  2010-11-10       Impact factor: 2.373

6.  Cost-effectiveness of olanzapine as first-line treatment for schizophrenia: results from a randomized, open-label, 1-year trial.

Authors:  Sandra L Tunis; Douglas E Faries; Allen W Nyhuis; Bruce J Kinon; Haya Ascher-Svanum; Ralph Aquila
Journal:  Value Health       Date:  2006 Mar-Apr       Impact factor: 5.725

7.  Statistical methods for analyzing sequentially randomized trials.

Authors:  Oliver Bembom; Mark J van der Laan
Journal:  J Natl Cancer Inst       Date:  2007-10-30       Impact factor: 13.506

8.  Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis.

Authors:  Maya L Petersen; Yue Wang; Mark J van der Laan; David Guzman; Elise Riley; David R Bangsberg
Journal:  Clin Infect Dis       Date:  2007-08-20       Impact factor: 9.079

9.  A targeted maximum likelihood estimator of a causal effect on a bounded continuous outcome.

Authors:  Susan Gruber; Mark J van der Laan
Journal:  Int J Biostat       Date:  2010-08-01       Impact factor: 0.968

10.  Discussion of Evaluation of Viable Dynamic Treatment Regimes in a Sequentially Randomized Trial of Advanced Prostate Cancer, by Wang et al. 2012.

Authors:  Paul Chaffee; Mark van der Laan
Journal:  J Am Stat Assoc       Date:  2012-07-24       Impact factor: 5.033

View more
  1 in total

1.  Comparing dynamic treatment regimes using repeated-measures outcomes: modeling considerations in SMART studies.

Authors:  Xi Lu; Inbal Nahum-Shani; Connie Kasari; Kevin G Lynch; David W Oslin; William E Pelham; Gregory Fabiano; Daniel Almirall
Journal:  Stat Med       Date:  2015-12-06       Impact factor: 2.373

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.